Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib effectively treats severe alopecia areata and is safe.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Pexidartinib often causes liver issues and fatigue, especially in women.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

RF-mesotherapy with bicalutamide may be a promising new treatment for hair loss.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

JAK inhibitors may help improve symptoms in adults with APECED.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Baricitinib successfully treated severe hair loss.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Tadalafil and Finasteride may help treat aggressive melanoma.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Baricitinib was effective in treating both early and late onset alopecia areata.